About this episode
As competitors publicly entered the race to produce a vaccine, drug giant Merck stayed quiet about its development plans. Now, the company has revealed it’s working on two vaccines and a treatment pill -- emerging as a frontrunner in the development contest. Although the company has refused to give firm timelines for its research, it has pledged to make its vaccines and pill available globally, if they're successful. Riley Griffin talked with Merck Chief Executive Kenneth C. Frazier about the company's plans.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Prognosis: Misconception publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Prognosis: Misconception
Introducing: Levittown
Prognosis: Misconception
Listen Now: Beak Capitalism from Odd Lots
Prognosis: Misconception
Misconception: Great Expectations
Prognosis: Misconception
Misconception: Big Baby
Prognosis: Misconception